UBS raised the firm’s price target on Ameren (AEE) to $114 from $113 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEE:
- Ameren’s Growth Prospects and Strategic Initiatives Justify Buy Rating
- Ameren price target lowered to $102 from $103 at Morgan Stanley
- Ameren Enters Forward Sale Agreements with Major Banks
- UnitedHealth, Wayfair downgraded: Wall Street’s top analyst calls
- Ameren price target raised to $112 from $108 at Wells Fargo